Shanghai MicroPort MedBot (Group) Co., Ltd. (HKG:2252)
Hong Kong · Delayed Price · Currency is HKD | Market Cap | 25.04B +33.9% |
| Revenue (ttm) | 365.66M +113.6% |
| Net Income | -524.44M |
| EPS | -0.53 |
| Shares Out | 1.03B |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 6,705,985 |
| Average Volume | 6,397,458 |
| Open | 23.80 |
| Previous Close | 24.28 |
| Day's Range | 22.92 - 24.66 |
| 52-Week Range | 13.50 - 33.70 |
| Beta | 1.53 |
| RSI | 35.63 |
| Earnings Date | Mar 27, 2026 |
About HKG:2252
Shanghai MicroPort MedBot (Group) Co., Ltd. engages in the research and development, design, manufacture, and sale of surgical robots in the People’s Republic of China. The company offers Toumai, a laparoscopic surgical robot for use in urologic, gynecologic, thoracic, and general surgeries; DFVision, a 3D electronic laparoscope, which is used in laparoscopic surgeries for abdominal, thoracic, and pelvic organs; SkyWalker, an orthopedic surgical robot for knee arthroplasty and hip arthroplasty; R-One, a vascular interventional surgical robot fo... [Read more]
Financial Performance
In 2024, HKG:2252's revenue was 257.25 million, an increase of 145.95% compared to the previous year's 104.59 million. Losses were -642.41 million, -36.53% less than in 2023.
Financial numbers in CNY Financial StatementsNews
AI surgery: Chinese robot conducts complex operation on pig without human intervention
A robot developed by a Chinese company has successfully performed a biliary surgery on a 30kg pig, using an AI model to perform the procedure autonomously. The experiment, which took place on December...